151 related articles for article (PubMed ID: 14511009)
1. Cutaneous side-effects of treatment of chronic hepatitis C by interferon alfa and ribavirin.
Kerl K; Negro F; Lübbe J
Br J Dermatol; 2003 Sep; 149(3):656. PubMed ID: 14511009
[No Abstract] [Full Text] [Related]
2. Diffuse cutaneous eruption due to interferon alfa and ribavirin treatment of chronic hepatitis C.
Savk E; Uslu G; Karaoğlu AO; Sendur N; Karaman G
J Eur Acad Dermatol Venereol; 2005 May; 19(3):396-8. PubMed ID: 15857485
[No Abstract] [Full Text] [Related]
3. Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus.
Manjón-Haces JA; Vázquez-López F; Gómez-Díez S; Hidalgo-García A; Pérez-Alvarez R; Soler-Sánchez T; Pérez-Oliva N
Acta Derm Venereol; 2001; 81(3):223. PubMed ID: 11558891
[No Abstract] [Full Text] [Related]
4. Meyerson's phenomenon induced by interferon-alfa plus ribavirin in hepatitis C infection.
Girard C; Bessis D; Blatìre V; Guilhou JJ; Guillot B
Br J Dermatol; 2005 Jan; 152(1):182-3. PubMed ID: 15656829
[No Abstract] [Full Text] [Related]
5. Sarcoidosis during combined interferon alfa and ribavirin therapy in 2 patients with chronic hepatitis C.
Wendling J; Descamps V; Grossin M; Marcellin P; Le Bozec P; Belaich S; Crickx B
Arch Dermatol; 2002 Apr; 138(4):546-7. PubMed ID: 11939833
[No Abstract] [Full Text] [Related]
6. High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus.
Sookoian S; Neglia V; Castaño G; Frider B; Kien MC; Chohuela E
Arch Dermatol; 1999 Aug; 135(8):1000-1. PubMed ID: 10456365
[No Abstract] [Full Text] [Related]
7. Eczema-like lesions and disruption of therapy in patients treated with interferon-alfa and ribavirin for chronic hepatitis C: the value of an interdisciplinary assessment.
Vázquez-López F; Manjón-Haces JA; Pérez-Alvarez R; Pérez-Oliva N
Br J Dermatol; 2004 May; 150(5):1046-7; author reply 1047. PubMed ID: 15149535
[No Abstract] [Full Text] [Related]
8. Cutaneous reactions to interferon and ribavirin.
Chamberlain AJ; Poon E
Intern Med J; 2004 Aug; 34(8):519. PubMed ID: 15317557
[No Abstract] [Full Text] [Related]
9. Meyerson's naevi induced by interferon alfa plus ribavirin combination therapy in hepatitis C infection.
Conde-Taboada A; de la Torre C; Feal C; Mayo E; Gonzalez-Sixto B; Cruces MJ
Br J Dermatol; 2005 Nov; 153(5):1070-2. PubMed ID: 16225630
[No Abstract] [Full Text] [Related]
10. Cutaneous sarcoidosis during interferon alfa and ribavirin treatment of hepatitis C virus infection: two cases.
Cogrel O; Doutre MS; Marlière V; Beylot-Barry M; Couzigou P; Beylot C
Br J Dermatol; 2002 Feb; 146(2):320-4. PubMed ID: 11903249
[TBL] [Abstract][Full Text] [Related]
11. Severe, generalized nummular eczema secondary to interferon alfa-2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection.
Moore MM; Elpern DJ; Carter DJ
Arch Dermatol; 2004 Feb; 140(2):215-7. PubMed ID: 14967798
[TBL] [Abstract][Full Text] [Related]
12. Papular Sarcoidosis of the Knees Following Treatment with Interferon Alpha and Ribavirin in a Woman with Hepatitis C.
Monteagudo B; Grueiro MC; Vilas-Sueiro A; Campo-Cerecedo F
Actas Dermosifiliogr (Engl Ed); 2019 Dec; 110(10):871-873. PubMed ID: 31387690
[No Abstract] [Full Text] [Related]
13. Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: a series of 20 patients.
Dereure O; Raison-Peyron N; Larrey D; Blanc F; Guilhou JJ
Br J Dermatol; 2002 Dec; 147(6):1142-6. PubMed ID: 12452863
[TBL] [Abstract][Full Text] [Related]
14. A case of irreversible alopecia associated with ribavirin and peg-interferon therapy.
Shafa S; Borum ML; Igiehon E
Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):122-3. PubMed ID: 19959941
[No Abstract] [Full Text] [Related]
15. Severe allergic eczema due to pegylated alpha-interferon may abate after switching to daily conventional alpha-interferon.
Veldt BJ; Schalm SW; Janssen HL
J Clin Gastroenterol; 2007 Apr; 41(4):432. PubMed ID: 17413616
[No Abstract] [Full Text] [Related]
16. Clinical and immunological features of hepatitis C treatment-associated dermatitis in 36 prospective cases.
Lübbe J; Kerl K; Negro F; Saurat JH
Br J Dermatol; 2005 Nov; 153(5):1088-90. PubMed ID: 16225644
[No Abstract] [Full Text] [Related]
17. A longitudinal cohort study of mucocutaneous drug eruptions during interferon and ribavirin treatment of hepatitis C.
Tavakoli-Tabasi S; Bagree A
J Clin Gastroenterol; 2012 Feb; 46(2):162-7. PubMed ID: 21814144
[TBL] [Abstract][Full Text] [Related]
18. Adverse skin reactions associated with hepatitis C treatment: comment.
Lübbe J
J Dermatol; 2008 Apr; 35(4):250; author reply 251. PubMed ID: 18419688
[No Abstract] [Full Text] [Related]
19. Cutaneous reactions in patients with chronic hepatitis C treated with peginterferon and ribavirin.
Patrk I; Morović M; Markulin A; Patrk J
Dermatology; 2014; 228(1):42-6. PubMed ID: 24434490
[TBL] [Abstract][Full Text] [Related]
20. Exacerbation of oral lichen planus lesions during treatment of chronic hepatitis C with pegylated interferon and ribavirin.
Grossmann Sde M; Teixeira R; de Aguiar MC; do Carmo MA
Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):702-6. PubMed ID: 18679075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
